1029-1030 Joost van Hoof Psychological responses to the proximity of climate change pp. 1028-1029 Richard Matear and Andrew Lenton Female thermal demand pp. 1027-1027 Mat Hope Restoration of the oceans pp. 1027-1027 Eithne Tynan Geoengineering challenges pp. 1027-1027 Bronwyn Wake Regional loss impacts pp. 1027-1027 Alastair Brown Monsoon uncertainties pp. 1025-1026 Victoria Hurth and Patricia McCarney Rapid adaptation pp.
1024-1025 Erin Roberts, Stephanie Andrei, Saleemul Huq and Lawrence Flint International standards for climate-friendly cities pp. Nassikas Resilience synergies in the post-2015 development agenda pp. Volume 5, isA role for tropical forests in stabilizing atmospheric CO2 pp.
#JASON SCHWARTZ SOCIAL COST METHANE ARCHIVE#
Is something missing from the series or not right? See the RePEc data check for the archive and series. Track citations for all items by RSS feed in the history and sociology of science and a master's degree (MBE) in bioethics.Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing (). in classics, and the University of Pennsylvania, where he received a Ph.D. Schwartz is a graduate of Princeton University, where he received an A.B. Public Health Service-led STD research in Guatemala in the 1940s. He was also a staff member for President Barack Obama's Presidential Commission for the Study of Bioethical Issues, where he was a lead staff author of the Commission's 2010 report on synthetic biology and emerging technologies and a contributor to its 2011 investigation of U.S. Shapiro Fellow at the Princeton University Center for Human Values, and earlier, an Associate Fellow and Lecturer in the Department of Medical Ethics and Health Policy at the University of Pennsylvania Perelman School of Medicine. Prior to arriving at Yale, Schwartz was the Harold T. He also advised colleges and universities, K-12 schools, early childhood centers, churches, and other organizations regarding their COVID-19 policies and protocols, particularly with respect to vaccines. Ned Lamont's COVID-19 Vaccine Advisory Group and chair of its Science Subcommittee. He is a member of The Lancet Commission on Vaccine Acceptance in the United States and the New England Comparative Effectiveness Public Advisory Council for the Institute for Clinical and Economic Review (ICER).ĭuring the COVID-19 pandemic, Schwartz was a member of Connecticut Gov. House Oversight Subcommittee on Economic and Consumer Policy, the National Vaccine Advisory Committee, and the Presidential Commission for the Study of Bioethical Issues. His research, analysis, and perspectives have appeared in the New York Times, Washington Post, CNN, NPR, BBC, Time, and elsewhere. health care system, pharmaceuticals and the FDA, science advice to government, and related topics. Schwartz regularly teaches courses and gives lectures on vaccination issues, health policy and the U.S. Other ongoing projects examine how policy-makers, regulators, payers, physicians, and patients evaluate and respond to the risks, benefits, and costs of medical interventions. This project is supported by the National Institutes of Health. Among his current research projects is a book, Solicited Advice: Expert Committees, Government Health Agencies, and Medicine in Modern America, that examines the emergence, evolution, and continuing influence of expert advisory committees in American medicine and public health from the 1960s to the present, particularly regarding pharmaceuticals, vaccines, and screening technologies. He is also an author of the chapter titled “Ethics” in Plotkin's Vaccines, the leading textbook of vaccine science and policy, and editor of Vaccination Ethics and Policy: An Introduction with Readings. Schwartz's publications have appeared in The New England Journal of Medicine, The Journal of the American Medical Association (JAMA), The American Journal of Public Health, BMJ, The Lancet, Health Affairs, and elsewhere. He holds a secondary appointment in the Section of the History of Medicine at the Yale School of Medicine and is also affiliated with Yale's Institution for Social and Policy Studies and Program in the History of Science and Medicine. The overall focus of his work is on the ways in which evidence is interpreted, evaluated, and translated into regulation and policy in medicine and public health. His research examines vaccines and vaccination policy, decision-making in medical regulation and public health policy, and the structure and function of scientific expert advice to government.
Schwartz is an Associate Professor in the Department of Health Policy and Management at the Yale School of Public Health.
0 kommentar(er)
